Skip to content

Prognosis of Idiopathic CD4 Lymphocytopenia in children

Prognosis of Idiopathic CD4 Lymphocytopenia in children - PROLIC (Prognosis of Idiopathic CD4 Lymphocytopenia in children)

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON38721
Enrollment
150
Registered
2013-08-02
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ICL Idiopatische CD4 lymphopenia

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
2 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Age between 0 to 16 - Lymphopenic two or more occasions, separated by at least a month (identified by pre-clinical screening, see research protocol) - Good understanding of the Dutch language

Exclusion criteria

Exclusion criteria: - Immunosuppressive co-morbidities explaining lymphopenia - Immunosuppressive medication explaining lymphopenia - Unavailability for follow-up research (immigration, mortality)

Design outcomes

Primary

MeasureTime frame
- CD4 cell counts - Medical history defined by the questionnaire and medical files provided by the general practitioner.

Secondary

MeasureTime frame
- Number of first degree family members affected by ICL.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)